Serum levels of circulating microRNA-107 are elevated in patients with early-stage HCC
Fig 2
MiRNA-107 levels are upregulated in HCC patients.
(A) Circulating miR-107 levels are significantly higher in HCC patients compared to healthy controls. (B) Circulating miR-107 levels show an AUC value of 0.679 regarding the discrimination between HCC and healthy controls.